Odawara, Japan

Yoshihiko Terayama

This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiko Terayama. Retrieved from https://idiyas.com/inventor/yoshihiko-terayama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yoshihiko Terayama

Introduction

Yoshihiko Terayama is a notable inventor based in Odawara, Japan. He has made significant contributions to the field of medical technology, particularly in the development of X-ray-intercepting metal complexes.

Latest Patents

One of his key patents is focused on X-ray intercepting metal complexes of chlorin derivatives. This innovative patent describes an X-ray-intercepting gold complex of mono-L-aspartyl (or mono-L-glutamyl) chlorin e6 or a salt thereof. It is utilized in the therapy of tumors, cancer, or arteriosclerosis lesions through X-ray irradiation. The complex is designed to provide a sharp X-ray image of tumors, solid cancers, or lesions of arteriosclerosis. Additionally, a similar platinum complex may also be employed in this therapeutic approach.

Career Highlights

Yoshihiko Terayama is associated with Meiji Seika Kaisha, Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer treatment and diagnostic imaging.

Collaborations

He has collaborated with notable colleagues, including Katsuo Aizawa and Shinjiro Sumi, to further enhance the development of his inventions.

Conclusion

Yoshihiko Terayama's contributions to medical technology through his innovative patents demonstrate his commitment to improving healthcare solutions. His work in X-ray imaging and therapy continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…